Page last updated: 2024-11-02

pd 98059 and Osteoporosis

pd 98059 has been researched along with Osteoporosis in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W1
Ma, Y1
Ye, H1
He, Y1
Li, X1
Li, J1
Zhu, Z1
Wang, H1
Ahlstrom, M1
Pekkinen, M1
Riehle, U1
Lamberg-Allardt, C1

Other Studies

2 other studies available for pd 98059 and Osteoporosis

ArticleYear
ERK1/2 is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells.
    Biochemical and biophysical research communications, 2010, Oct-22, Volume: 401, Issue:3

    Topics: Animals; Bone Resorption; Cell Line; Cell Survival; Compressive Strength; Flavonoids; Interleukin-6;

2010
Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells.
    Bone, 2008, Volume: 42, Issue:3

    Topics: Bone Resorption; Calcium; Core Binding Factor Alpha 1 Subunit; Dactinomycin; Female; Flavonoids; Gen

2008